Therefore, it can be said that monitoring Lp‐PLA2 and CTRP3 in patients with T2DM will be helpful to early warning and diagnosis of CVD, and take on clinical significance in improving the prognosis of the disease. The gene discussed is PLA2G7; the disease is type 2 diabetes mellitus.